These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 8422382

  • 1. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
    Taylor A, Peltier CZ, Torre FJ, Hakamian N.
    Biochemistry; 1993 Jan 26; 32(3):784-90. PubMed ID: 8422382
    [Abstract] [Full Text] [Related]

  • 2. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase.
    Taylor A, Peltier CZ, Jahngen EG, Laxman E, Szewczuk Z, Torre FJ.
    Biochemistry; 1992 Apr 28; 31(16):4141-50. PubMed ID: 1567860
    [Abstract] [Full Text] [Related]

  • 3. The slow, tight binding of bestatin and amastatin to aminopeptidases.
    Wilkes SH, Prescott JM.
    J Biol Chem; 1985 Oct 25; 260(24):13154-62. PubMed ID: 2865258
    [Abstract] [Full Text] [Related]

  • 4. X-ray crystallographic determination of the structure of bovine lens leucine aminopeptidase complexed with amastatin: formulation of a catalytic mechanism featuring a gem-diolate transition state.
    Kim H, Lipscomb WN.
    Biochemistry; 1993 Aug 24; 32(33):8465-78. PubMed ID: 8357796
    [Abstract] [Full Text] [Related]

  • 5. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.
    Burley SK, David PR, Lipscomb WN.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):6916-20. PubMed ID: 1871107
    [Abstract] [Full Text] [Related]

  • 6. Re-refinement of the X-ray crystal structure of bovine lens leucine aminopeptidase complexed with bestatin.
    Kim H, Burley SK, Lipscomb WN.
    J Mol Biol; 1993 Apr 05; 230(3):722-4. PubMed ID: 8478928
    [Abstract] [Full Text] [Related]

  • 7. Transition state analogue L-leucinephosphonic acid bound to bovine lens leucine aminopeptidase: X-ray structure at 1.65 A resolution in a new crystal form.
    Sträter N, Lipscomb WN.
    Biochemistry; 1995 Jul 18; 34(28):9200-10. PubMed ID: 7619821
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Leucine aminopeptidase (bovine lens): synthesis and kinetic properties of ortho-, meta-, and para-substituted leucyl-anilides.
    Taylor A, Tisdell FE, Carpenter FH.
    Arch Biochem Biophys; 1981 Aug 18; 210(1):90-7. PubMed ID: 7294838
    [No Abstract] [Full Text] [Related]

  • 15. Differentiation and identification of the two catalytic metal binding sites in bovine lens leucine aminopeptidase by x-ray crystallography.
    Kim H, Lipscomb WN.
    Proc Natl Acad Sci U S A; 1993 Jun 01; 90(11):5006-10. PubMed ID: 8506345
    [Abstract] [Full Text] [Related]

  • 16. Mechanistic implications of the inhibition of peptidases by amino aldehydes and bestatin.
    Frick L, Wolfenden R.
    Biochim Biophys Acta; 1985 Jul 01; 829(3):311-8. PubMed ID: 3890953
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
    Chandra D, Ramana KV, Wang L, Christensen BN, Bhatnagar A, Srivastava SK.
    Invest Ophthalmol Vis Sci; 2002 Jul 01; 43(7):2285-92. PubMed ID: 12091429
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.